TrialEuropean journal of human genetics : EJHG2015

Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.

David J Kwiatkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.